Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry

被引:29
作者
Weimann, A [1 ]
Sabroe, M [1 ]
Poulsen, HE [1 ]
机构
[1] Rigshosp, Dept Clin Pharmacol Q7642, DK-2200 Copenhagen, Denmark
来源
JOURNAL OF MASS SPECTROMETRY | 2005年 / 40卷 / 03期
关键词
caffeine; metabolites; electrospray; urine;
D O I
10.1002/jms.785
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Analysis of caffeine and its metabolites is of interest with respect to caffeine exposure, for kinetic and metabolism studies and for opportunistic in vivo estimation of drug metabolizing enzyme activity in humans and animals. For the latter, analysis is usually done by high-performance liquid chromatography (HPLC) with UV detection. However, this method is close to the detection limit for certain of the metabolites and requires very long chromatography, 30-60 min. We have developed a fast method for the quantification of caffeine and its metabolites 1-methylxanthine, 1-methyluric acid, 1,7-dimethyluric acid, 5-acetylamino-6-amino-3-methyluracil (AAMU) and 5-acetylamino-6-fonnylamino-3-methyluracil (AFMU) by HPLC tandem mass spectrometry (MS/MS) in urine that requires only its dilution with buffer and centrifugation before injection into the HPLC/MS/MS system. The chromatography lasts 7 min and is followed by 4.5 min for re-equilibration of the HPLC column, giving a total analysis time of 11.5 min. The method provides a great sensitivity improvement with detection limits for all analytes <= 25 nM in real samples. Also, the analysis provides much improvement in capacity to similar to 125 samples per 24 h. Intra- and inter-day coefficients of variation of a single analysis are < 6.5% for all the analytes. The inter-day coefficient of variation of duplicate analyses is < 4.8% for all analytes. The method is automated, including automated integration, and it is fast, robust and suitable for large-scale investigations in humans and animals. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 37 条
[1]   Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry [J].
Baud-Camus, F ;
Marquet, P ;
Soursac, M ;
Davrinche, C ;
Farinotti, R .
JOURNAL OF CHROMATOGRAPHY B, 2001, 760 (01) :55-63
[2]   Liquid chromatographic method for the simultaneous determination of caffeine and fourteen caffeine metabolites in urine [J].
Bendriss, EK ;
Markoglou, N ;
Wainer, IW .
JOURNAL OF CHROMATOGRAPHY B, 2000, 746 (02) :331-338
[3]   FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J].
BROSEN, K ;
SKJELBO, E ;
RASMUSSEN, BB ;
POULSEN, HE ;
LOFT, S .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1211-1214
[4]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[5]  
CAMPBELL ME, 1987, DRUG METAB DISPOS, V15, P237
[6]   A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE [J].
CAMPBELL, ME ;
SPIELBERG, SP ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :157-165
[7]   Determination of urinary 13C-caffeine metabolites by liquid chromatography-mass spectrometry:: the use of metabolic ratios to assess CYP1A2 activity [J].
Caubet, MS ;
Comte, B ;
Brazier, JL .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 34 (02) :379-389
[8]   Determination of urinary methylated purine pattern by high-performance liquid chromatography [J].
Di Pietro, MC ;
Vannoni, D ;
Leoncini, R ;
Liso, G ;
Guerranti, R ;
Marinello, E .
JOURNAL OF CHROMATOGRAPHY B, 2001, 751 (01) :87-92
[9]   RAPID METHOD FOR THE ROUTINE DETERMINATION OF CAFFEINE AND ITS METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DOBROCKY, P ;
BENNETT, PN ;
NOTARIANNI, LJ .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 652 (01) :104-108
[10]  
FUJII T, 2001, CHEM PHARM BULL, V39, P2855